In the article, Yuergens outlines how each type of phase converter delivers power differently. He explains that selecting the ...

(RTTNews) - NovaBridge Biosciences (NBP) on Tuesday reported positive updated results from its Phase 1b combination study of givastomig with nivolumab and chemotherapy in patients with HER2-negative, ...

Stretching has long been a topic of debate among athletes, coaches, and healthcare professionals regarding its benefits and optimal use. Conflicting scientific evidence on whether stretching improves ...

VERO BEACH, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies, today provided ...

SAN DIEGO, Dec. 9, 2025 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced that they will ...

The MarketWatch News Department was not involved in the creation of this content. -- In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone ...

A key Zcash developer has published the first detailed blueprint for a dynamic fee market, opening a community discussion about how the decade-old network should price transactions as ZEC’s price, ...

VANCOUVER, British Columbia, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...

Complete Response in all treated lesions: Patients completing the study showed CR via the MD Anderson Criteria and RECIST v1.1 with no active tumor detected on MRI First-of-its-kind single ...